Reducing risk of cardiovascular events in noncardiac surgery

Author： Passamonti Enrico   Pirelli Salvatore  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.9, 2005-08, pp. : 1507-1515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?

By  

Current Drug Targets, Vol. 10, Iss. 9, 2009-09 ,pp. : 863-871

Bentham Science Publishers

Access to resources Recommend Favorite

Ephedra: risk of adverse cardiovascular events

By  

Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

CARDS: atorvastatin reduces risk of cardiovascular events in diabetes

By  

Inpharma, Vol. 1, Iss. 1446, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

β-Blockers Reduce Mortality in Patients Undergoing High-Risk Non-Cardiac Surgery

By Angeli Fabio  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 247-259

Adis International

Access to resources Recommend Favorite

Management of Antiplatelet Therapy inPatients at Risk for Coronary StentThrombosis Undergoing Non-Cardiac Surgery

By Motovska Zuzana  

Drugs, Vol. 71, Iss. 14, 2011-10 ,pp. : 1797-1806

Adis International

Access to resources Recommend Favorite